Dr Dongli Liu is an early-mid career cancer researcher and educator. She currently works at the Gynaecological Cancer Research Group at the University of New South Wales in Sydney, Australia (Academic Level B) with a focus on novel biomarkers and therapies in gynaecological diseases. She has extensive research experience in molecular and cell biology techniques including patient-derived primary cell culture as well as bioinformatics skills for next generation sequencing (NGS). During her 8 years of postdoctoral research, Dr Liu has led a number of research projects in collaboration with other research groups, clinicians, and industry partners; securing over $1 million in research grants.